KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Rad Laboratories (BIO) Equity Ratio (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Equity Ratio for 17 consecutive years, with 0.7 as the latest value for Q4 2025.

  • Quarterly Equity Ratio changed 0.45% to 0.7 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.7 through Dec 2025, changed 0.45% year-over-year, with the annual reading at 0.7 for FY2025, 0.45% changed from the prior year.
  • Equity Ratio for Q4 2025 was 0.7 at Bio-Rad Laboratories, up from 0.69 in the prior quarter.
  • The five-year high for Equity Ratio was 13685.2 in Q4 2021, with the low at 0.69 in Q3 2025.
  • Average Equity Ratio over 5 years is 725.8, with a median of 0.71 recorded in 2022.
  • The sharpest move saw Equity Ratio crashed 99.84% in 2022, then surged 3376.95% in 2024.
  • Over 5 years, Equity Ratio stood at 13685.2 in 2021, then plummeted by 99.84% to 21.42 in 2022, then surged by 42.11% to 30.45 in 2023, then tumbled by 97.7% to 0.7 in 2024, then rose by 0.45% to 0.7 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.7, 0.69, and 0.7 for Q4 2025, Q3 2025, and Q2 2025 respectively.